Compare TLSI & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLSI | ATLO |
|---|---|---|
| Founded | 2010 | 1903 |
| Country | United States | United States |
| Employees | 102 | N/A |
| Industry | Medical Specialities | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.2M | 248.3M |
| IPO Year | N/A | 2001 |
| Metric | TLSI | ATLO |
|---|---|---|
| Price | $3.15 | $27.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 590.8K | 56.8K |
| Earning Date | 05-12-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 3.43% |
| EPS Growth | N/A | ★ 8.03 |
| EPS | N/A | ★ 0.38 |
| Revenue | N/A | N/A |
| Revenue This Year | $35.45 | N/A |
| Revenue Next Year | $37.58 | N/A |
| P/E Ratio | ★ N/A | $73.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.20 | $16.94 |
| 52 Week High | $7.95 | $29.71 |
| Indicator | TLSI | ATLO |
|---|---|---|
| Relative Strength Index (RSI) | 36.08 | 46.38 |
| Support Level | N/A | $27.72 |
| Resistance Level | $5.41 | $28.28 |
| Average True Range (ATR) | 0.33 | 0.69 |
| MACD | -0.17 | -0.09 |
| Stochastic Oscillator | 38.93 | 29.23 |
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.